An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT07027527 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07027527
- Sponsor
- Apogee Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-04
- Primary completion
- 2026-12-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.